Company: GEHC
Filing Date: 2025-04-30
Form Type: 10-Q
Source: 0001932393-25-000014
Chunk: 18

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-04-30
Form: 10-Q
Item: Item 8
Chunk 18
---
.The tables below present the gains (losses) on our derivative financial instruments and hedging activity in the Condensed Consolidated Statements of Income.Derivative Financial Instruments and Hedging ActivityFor the three months ended March 31, 2025Cost of productsCost of servicesSG&AInterest and other financial charges – netOther(4)Foreign currency forward contracts$(2)$(1)$— $— $— Effects of cash flow hedges(2)(1)— — — Cross-currency swaps— — — 8 — Foreign currency forward and options contracts— — — 3 — Effects of net investment hedges(1)— — — 11 — Interest rate swaps(2)— — — 57 — Debt basis adjustment on Long-term borrowings— — — (61)— Effects of fair value hedges— — — (4)— Foreign currency forward contracts15 4 — — (1)Other derivatives(3)— — (3)— (15)Effects of derivatives not designated as hedging instruments15 4 (3)— (15)For the three months ended March 31, 2024Cost of productsCost of servicesSG&AInterest and other financial charges – netOther(4)Foreign currency forward contracts$(1)$— $— $— $— Effects of cash flow hedges(1)— — — — Cross-currency swaps— — — 8 — Foreign currency forward and option contracts— — — 2 — Effects of net investment hedges(1)— — — 10 — Interest rate swaps(2)— — — (45)— Debt basis adjustment on Long-term borrowings— — — 38 — Effects of fair value hedges— — — (6)— Foreign currency forward contracts(12)(3)— — — Other derivatives(3)— — 5 — 20 Effects of derivatives not designated as hedging instruments(12)(3)5 — 20 (1) Changes in fair value related to components other than the spot rate are excluded from effectiveness testing for the three months ended March 31, 2025 and 2024.(2) Amount includes $(4) million and $(6)